Doctor profile · Federal record
Dr. JULIE MORLEY, PAC
Medical Physician Assistant (CMS: PHYSICIAN ASSISTANT) · PINEHURST, NC
- NPI 1073617577
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
125 FOX HOLLOW ROAD, SUITE 210
PINEHURST, NC 28374
(910) 295-7546
fax (910) 692-2831
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- North Carolina #102999
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073617577. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,009
Distinct HCPCS
10
Medicare allowed
$207,138
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,983 | 348 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,001 | 740 | $74 | |
17000 |
Destruction of precancer skin growth, 1 growth | 656 | 506 | $42 | |
17110 |
Destruction of skin growth, 1-14 growths | 387 | 320 | $90 | |
11102 |
Biopsy of related skin growth, first growth | 280 | 253 | $73 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 158 | 142 | $46 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 143 | 143 | $92 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 133 | 28 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 69 | 51 | $41 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 40 | 34 | $105 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 232. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$1,172
Transactions
45
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $425.77 | |
| ABBVIE INC. | 10 | $338.79 | |
| Janssen Biotech, Inc. | 11 | $294.76 | |
| Novartis Pharmaceuticals Corporation | 4 | $82.34 | |
| GENZYME CORPORATION | 1 | $16.03 | |
| Lilly USA, LLC | 1 | $14.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,057
Patients
507
Total drug cost
$917,455
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 245 | 135 | $2,190 |
| Doxycycline Hyclate | Generic | 154 | 70 | $4,964 |
| Mometasone Furoate | Generic | 133 | 84 | $3,207 |
| Ketoconazole | Generic | 126 | 70 | $3,694 |
| Mupirocin | Generic | 57 | 38 | $579 |
| Humira(Cf) Pen (Adalimumab) | Brand | 52 | 0 | $441,544 |
| Clobetasol Propionate | Generic | 51 | 31 | $2,541 |
| Metronidazole | Generic | 42 | 29 | $2,945 |
| Otezla (Apremilast) | Brand | 41 | 0 | $197,195 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 32 | 0 | $244,652 |